SAZ-VII-23

N/A

Report date: 2023/05/22 10:18:15

Base Information

Drug NameSAZ-VII-23

Drug Alias NameN/A

ClassificationSmall molecules

Mechanisms of ActionATPase inhibitors

TargetsATPase

Therapy Area/IndicationsArrhythmias, Cardiac

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesThe University Of Oklahoma

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive Companies +[1] N/A

Active IndicationsN/A

Inactive IndicationsArrhythmias, Cardiac

Other Information

ATC CodeN/A

Related LinksN/A